Trogenix
PrivateLast Round
Series A
Oct 6, 2025
Total Funding Raised
$133.95M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Trogenix is a biotechnology company that develops precision cancer treatments using its proprietary Odysseus® genetic medicine platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trogenix Comparables
Compare Trogenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Siren Biotechnology | 78% | |
| GeneCraft Inc. | 74% | |
| Chromatin Bioscience | 74% |
Trogenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 6, 2025 | ||||
| Seed | Nov 18, 2024 |
Key People
Founding team and executive leadership
Trogenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 4BIO Capital | Series A, Seed |
| Meltwind Advisory | Series A |
| IQ Capital | Seed, Series A |
| LongeVC | Series A |
| Old College Capital | Seed |
| Calculus Capital | Series A |
| Cancer Research Horizons | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Grew 17% QoQ, from 18 to 21 employees.
- May 17, 2026
Grew 18% QoQ, from 17 to 20 employees.
Trogenix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Trogenix's valuation, stock price, and market status.
Is Trogenix a public or private company?
Trogenix is a private company.
What is the current stock price of Trogenix?
Trogenix is a private company with no public stock price. No recent secondary market data is available.
How much is Trogenix worth (valuation)?
Valuation information for Trogenix is not publicly available.
Can I buy Trogenix stock?
Trogenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Trogenix's last funding round?
Trogenix's most recent funding round was Series A on October 6, 2025.
Who are the main investors in Trogenix?
Key investors in Trogenix include 4Bio Capital, IQ Capital.
Will Trogenix IPO soon?
No public IPO plans have been announced for Trogenix.
How can I track Trogenix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Trogenix's secondary market activity and sign up for updates.